Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vascular Endothelial Growth Factor”

398 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 398 results

Not applicableStudy completedNCT00978926
What this trial is testing

The Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignancy
National University Hospital, Singapore
Large-scale testing (Phase 3)UnknownNCT04572698
What this trial is testing

Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）

Who this might be right for
Age Related Macular Degeneration
Luye Pharma Group Ltd. 416
Large-scale testing (Phase 3)Study completedNCT01908426
What this trial is testing

Study of Cabozantinib (XL184) vs Placebo in Subjects With Hepatocellular Carcinoma Who Have Received Prior Sorafenib

Who this might be right for
Hepatocellular Carcinoma
Exelixis 707
Not applicableStudy completedNCT03115255
What this trial is testing

Serum Vascular Endothelial Growth Factor in Infants With Intravitreal Ranibizumab

Who this might be right for
Infant, Premature, Diseases
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 17
Testing effectiveness (Phase 2)Study completedNCT03797326
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

Who this might be right for
Advanced Solid TumorsTriple Negative Breast CancerOvarian Cancer+5 more
Merck Sharp & Dohme LLC 611
Testing effectiveness (Phase 2)UnknownNCT00744315
What this trial is testing

Induced Angiogenesis by Genic Therapy in Advanced Ischemic Cardiomyopathy

Who this might be right for
Ischemic Cardiopathy
Instituto de Cardiologia do Rio Grande do Sul 20
Not applicableStudy completedNCT04814329
What this trial is testing

Glioblastoma Response Prediction to Apatinib

Who this might be right for
Glioblastoma
Beijing Sanbo Brain Hospital 18
Not applicableStudy completedNCT00790803
What this trial is testing

Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema

Who this might be right for
UveitisCystoid Macular Edema
Wake Forest University 5
Large-scale testing (Phase 3)Study completedNCT00555594
What this trial is testing

Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization

Who this might be right for
Corneal Neovascularization
Asociación para Evitar la Ceguera en México 18
Testing effectiveness (Phase 2)Looking for participantsNCT07147348
What this trial is testing

A First-in-human, Dose Escalation and Indication Expansion Study of BNT3212 as Monotherapy or in Combination With BNT327 in Adults With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BioNTech SE 375
Not applicableUnknownNCT02810587
What this trial is testing

Endophthalmitis After Intravitreous Anti-VEGF Injections in Patients Receiving vs. Not Receiving Topical Antibiotics

Who this might be right for
Endophthalmitis
Chiang Mai University 5,000
Testing effectiveness (Phase 2)Looking for participantsNCT05769153
What this trial is testing

Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Alcon Research 140
Large-scale testing (Phase 3)Study completedNCT01865747
What this trial is testing

Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Exelixis 658
Post-approval studies (Phase 4)Study completedNCT01896284
What this trial is testing

Study to Evaluate Efficacy of Aflibercept in Neovascular Age-related Macular Degeneration Patients Non Responders to Anti-Vascular Endothelial Growth Factor

Who this might be right for
Wet Macular Degeneration
Barcelona Macula Foundation 46
Post-approval studies (Phase 4)WithdrawnNCT01891500
What this trial is testing

Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory Failure

Who this might be right for
Persistent Fetal Circulation SyndromeHypertension, Pulmonary, of Newborn, PersistentPersistent Pulmonary Hypertension of Newborn
University of Florida
Not applicableStudy completedNCT02881892
What this trial is testing

Iplasma IL6, Procalcitonin and VEGF and Dialysate Level in CAPD Patients

Who this might be right for
Chronic Kidney Disease
Bangkok Metropolitan Administration Medical College and Vajira Hospital 26
Not applicableUnknownNCT01310686
What this trial is testing

Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy

Who this might be right for
Wet AMD
West Coast Retina Medical Group, Inc. 40
Not applicableStudy completedNCT00970970
What this trial is testing

Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease

Who this might be right for
Von Hippel-Lindau DiseaseHemangioblastomaRenal Cell Carcinoma+2 more
University Medical Center Groningen 22
Early research (Phase 1)Study completedNCT02429843
What this trial is testing

TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Non-Squamous Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Alabama at Birmingham 16
Not applicableStudy completedNCT00005761
What this trial is testing

Blood Factors and Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
National Eye Institute (NEI) 173
Load More Results